Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Xenon Pharmaceuticals Inc. | f8k_022315.htm |
Exhibit 99.1
 |
Joshua P. McGinn, CEP
Senior Vice President, Western Region Relationship Management
American Stock Transfer & Trust Company, LLC
One Embarcadero Center – Suite 566
San Francisco, CA 94111
Office: 415.835-1313
|
February 19, 2015
Alberta Securities Commission
British Columbia Securities Commission
Ontario Securities Commission
RE: Xenon Pharmaceuticals Inc.
Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:
|
Date of meeting:
|
May 4, 2015
|
|
Record date for notice:
|
March 17, 2015
|
|
Record date for voting:
|
March 17, 2015
|
|
Beneficial ownership determination date:
|
March 17, 2015
|
|
Securities entitled to notice:
|
Common Shares
|
|
Securities entitled to vote:
|
Common Shares
|
|
Issuer mailing directly to non objecting beneficial owners:
|
No
|
|
Issuer will pay for objecting beneficial owner material distribution:
|
No
|
|
Issuer using notice-and-access for registered investors:
|
No
|
|
Issuer using notice-and-access for non-registered investors:
|
No
|
|
Notice-and-access stratification criteria:
|
N/A
|
Yours very truly,
Joshua P. McGinn
Senior Vice-President, Western Region
Relationship Management